Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of$ 0.44. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 13.64%. A quarter ago, it was expected that this company would post a loss of$ 0.45 per share when it actually produced a loss of $0.42, delivering a surprise of 6.67%.Over the last four quarters, the company has ...